Data

Systematically collected information used to understand patterns of substance use, substance use disorders, treatment needs, and drug market dynamics. This may include epidemiological data, service utilisation records, treatment outcomes, law enforcement intelligence, and public health surveillance. Data helps identify emerging trends, assess the effectiveness of prevention and treatment programmes, monitor trafficking and market activity, and guide evidence-informed policy and decision-making. Reliable data systems are essential for improving responses to substance use and ensuring that interventions are targeted, effective, and responsive to population needs. 

Synthetic cannabinoids: Reflections from Mauritius

Community update
During a recent engagement in Mauritius, I had the opportunity to hear the National Agency for Drug Control (NADC) present the National Drug Control Master Plan 2026–2030 and to share the suite of resources available through ISSUP. This...
Mauritius National Agency for Drug Control (NADC) present the National Drug Control Master Plan 2026–2030

Carfentanil Detected in Counterfeit Tablets and Powders: What the Substance Use Workforce Should Know

Community update
A new health alert reports carfentanil in counterfeit “M30” tablets and powders seized at the United States Southwest border. Carfentanil is an extremely potent synthetic opioid, and some tablets contained it without any fentanyl. The findings highlight how the appearance of an illicit tablet or powder cannot reliably indicate its contents or strength. Prevention, treatment and recovery professionals should reinforce overdose awareness, naloxone access and timely connections to care. Law enforcement, laboratories and public health partners should follow safe handling protocols, test comprehensively and share emerging drug market information quickly.
CFSRE NPS Discovery programme April 2026 Synthetic Opioid Alert